We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.24B
AUM Growth
-$107M
(-4.6%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-6.17%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
955
New
308
Increased
134
Reduced
160
Closed
350
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.3M |
| 2 |
Merck
MRK
|
+$28.9M |
| 3 |
Morgan Stanley
MS
|
+$28.2M |
| 4 |
Verizon
VZ
|
+$27.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$22.4M |
| 2 |
Duke Energy
DUK
|
+$22M |
| 3 |
Cognizant
CTSH
|
+$19.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$19M |
| 5 |
Eaton
ETN
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.11% |
| 2 | Healthcare | 14.85% |
| 3 | Industrials | 13.1% |
| 4 | Technology | 12.1% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
Eaton
ETN
$157B
| $5.24M | 0.23% |
62,952
-226,837
| -78% | -$18.4M |
|
127
Pentair
PNR
$10.2B
| $5.23M | 0.23% |
140,587
-18,326
| -12% | -$695K |
|
128
Qualcomm
QCOM
$176B
| $5.12M | 0.23% |
+67,317
| New | +$4.93M |
|
129
Cigna
CI
$76.6B
| $5.1M | 0.23% |
32,374
-48,037
| -60% | -$7.53M |
|
130
Hewlett Packard
HPE
$63.2B
| $5.09M | 0.23% |
340,767
+113,163
| +50% | +$1.71M |
|
131
General Mills
GIS
$19.2B
| $5.07M | 0.23% |
96,466
-134,679
| -58% | -$6.96M |
|
132
AvalonBay Communities
AVB
$27.1B
| $5.06M | 0.23% |
24,899
-3,760
| -13% | -$762K |
|
133
Host Hotels & Resorts
HST
$16.8B
| $5.05M | 0.23% |
277,403
-106,656
| -28% | -$2.01M |
|
134
Bio-Rad Laboratories Class A
BIO
$8.42B
| $5.03M | 0.22% |
16,085
+2,859
| +22% | +$856K |
|
135
Target
TGT
$62.1B
| $4.99M | 0.22% |
57,568
-143,514
| -71% | -$11.6M |
|
136
Revvity
RVTY
$12.3B
| $4.95M | 0.22% |
51,393
+39,994
| +351% | +$3.73M |
|
137
Fox Class A
FOXA
$23.2B
| $4.87M | 0.22% |
+132,880
| New | +$4.88M |
|
|
PPLI
138
People Inc
PPLI
$3.1B
| $4.8M | 0.21% |
123,496
-21,929
| -15% | -$875K |
|
139
Ciena
CIEN
$55.3B
| $4.75M | 0.21% |
115,465
+18,960
| +20% | +$730K |
|
140
Williams Companies
WMB
$90.5B
| $4.74M | 0.21% |
+169,138
| New | +$4.7M |
|
141
CACI
CACI
$10.8B
| $4.73M | 0.21% |
23,138
+20,241
| +699% | +$4M |
|
142
Veeva Systems
VEEV
$30.3B
| $4.59M | 0.21% |
+28,305
| New | +$4.12M |
|
143
DXC Technology
DXC
$1.63B
| $4.5M | 0.2% |
81,666
-51,021
| -38% | -$2.95M |
|
144
NNN REIT
NNN
$9.39B
| $4.41M | 0.2% |
+83,123
| New | +$4.44M |
|
|
ETFC
145
DELISTED
E*Trade Financial Corporation
ETFC
| $4.38M | 0.2% |
98,091
-39,862
| -29% | -$1.9M |
|
146
Etsy
ETSY
$7.65B
| $4.35M | 0.19% |
70,832
-474
| -0.7% | -$30.9K |
|
147
Expedia Group
EXPE
$31.2B
| $4.34M | 0.19% |
32,658
-136,639
| -81% | -$16.8M |
|
|
ATH
148
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $4.28M | 0.19% |
99,430
+86,569
| +673% | +$3.74M |
|
149
Credicorp
BAP
$30.9B
| $4.27M | 0.19% |
+18,657
| New | +$4.28M |
|
150
Targa Resources
TRGP
$60.4B
| $4.24M | 0.19% |
107,900
-19,264
| -15% | -$765K |
|
Similar funds
CCA
HPIA
GAMA
TWP
ACA
CAAM
RK
PCM
Stevens Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stevens Capital Management held 955 positions worth $2.24B, down 4.6% from $2.34B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Stevens Capital Management withdrew a net $138M in Q2 2019, closing 350 positions and reducing 160 holdings. Its most notable exit was Cognizant, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in Merck worth $30.2M.
- Stevens Capital Management's largest Q2 2019 buy was Merck: 377,581 shares worth $30.2M.
- Stevens Capital Management added most to Eli Lilly in Q2 2019, an estimated $31.3M increase.
- Stevens Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $22.4M.
- Stevens Capital Management fully exited Cognizant in Q2 2019, selling an estimated $19.2M.
- Stevens Capital Management's ten largest holdings make up 13% of its $2.24B portfolio in Q2 2019.
- Stevens Capital Management opened 308 new positions and closed 350 in Q2 2019.
- Stevens Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.24B.
Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.